학술논문

A Population Pharmacokinetic Meta-Analysis of Veliparib, a PARP Inhibitor, Across Phase 1/2/3 Trials in Cancer Patients
Document Type
Article
Source
In: Journal of Clinical Pharmacology. (Journal of Clinical Pharmacology, September 2021, 61(9):1195-1205)
Subject
Language
English
ISSN
15524604
00912700